Skip to main content

Andrea Arias Garcia

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca
Andrea  Arias  Garcia

Andrea Arias Garcia

Andrea  Arias  Garcia

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Research lines

Mejora del proceso de fertilización in vitro

IP: Maria del Pilar Reimundo Diaz-Fierros, Andrea Arias Garcia

Related news

The annual event offered a space for dialogue between the scientific community and society on how to address the future of ageing through research and innovation.

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Related professionals

Raul Juntas Morales

Raul Juntas Morales

Head of group
Peripheral Nervous System
Read more
Eduardo Fidel Tizzano

Eduardo Fidel Tizzano

Head of group
Genetics Medicine
Read more
Dario Fabian Gándara Sabatini

Dario Fabian Gándara Sabatini

Administration and Management
Neurotraumatology and Neurosurgery Research Unit (UNINN)
Read more
Laura Ludovica Gramegna .

Laura Ludovica Gramegna .

Junior researcher
Stroke research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.